J. W. G. Smith

2.4k total citations · 1 hit paper
46 papers, 1.5k citations indexed

About

J. W. G. Smith is a scholar working on Endocrinology, Epidemiology and Infectious Diseases. According to data from OpenAlex, J. W. G. Smith has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, 12 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in J. W. G. Smith's work include Diphtheria, Corynebacterium, and Tetanus (14 papers), Influenza Virus Research Studies (9 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). J. W. G. Smith is often cited by papers focused on Diphtheria, Corynebacterium, and Tetanus (14 papers), Influenza Virus Research Studies (9 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). J. W. G. Smith collaborates with scholars based in United Kingdom, Nepal and United States. J. W. G. Smith's co-authors include Susie Jun, Rowan T. Chlebowski, Silvana Spadafora, Devchand Paul, Robert M. Henshaw, Sant P. Chawla, Winnie Sohn, Michelle Fan, Roger Dansey and Martine P. Roudier and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

J. W. G. Smith

46 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

2010 516 citations David M. Thomas, Robert M. Henshaw et al. The Lancet Oncology profile →

Peers

J. W. G. Smith

ONCOL

RHEUM

PRM

OS

MB

Ourania Nicolatou‐Galitis Greece

Ben Kang South Korea

Sol Silverman United States

Jean‐Paul Saint‐André France

Masahiro Tanaka Japan

Carlos Marcelo Figueredo Brazil

Hideo Yoshioka Japan

Louis Marcellin France

Vincenzo Montinaro Italy

P Géhanno France

Ourania Nicolatou‐Galitis Greece

J. W. G. Smith

1.3k ×2.2

ONCOL

152 ×0.3

RHEUM

1.5k ×3.3

PRM

59 ×0.2

OS

137 ×0.5

MB

Citations per year, relative to J. W. G. Smith J. W. G. Smith (= 1×) peers Ourania Nicolatou‐Galitis

Countries citing papers authored by J. W. G. Smith

Since Specialization

Citations

This map shows the geographic impact of J. W. G. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. W. G. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. W. G. Smith more than expected).

Fields of papers citing papers by J. W. G. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. W. G. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. W. G. Smith. The network helps show where J. W. G. Smith may publish in the future.

Co-authorship network of co-authors of J. W. G. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of J. W. G. Smith. A scholar is included among the top collaborators of J. W. G. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. W. G. Smith. J. W. G. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Smith, J. W. G., et al.. (2023). Reimagining the NICU: a human-centered design approach to healthcare innovation. Journal of Perinatology. 43(S1). 40–44. 4 indexed citations

2.

Khan, Salman, Kathleen Tompkins, J. W. G. Smith, et al.. (2021). Assessment of the Field Utility of a Rapid Point-of-Care Test for SARS-CoV-2 Antibodies in a Household Cohort. American Journal of Tropical Medicine and Hygiene. 106(1). 156–159. 4 indexed citations

3.

Robson, Kate, J. W. G. Smith, & Michael Dunn. (2020). Towards an architecture of flexibility. Journal of Perinatology. 40(S1). 22–28. 1 indexed citations

4.

Lenney, Warren, et al.. (2016). Lessons learnt from a primary care asthma improvement project. npj Primary Care Respiratory Medicine. 26(1). 15075–15075. 5 indexed citations

5.

Drakatos, Panagis, et al.. (2016). The use of an online Epworth Sleepiness Scale to assess excessive daytime sleepiness. Sleep And Breathing. 21(2). 333–340. 24 indexed citations

6.

Romaguera, Jorge, Luis Fayad, Peter McLaughlin, et al.. (2010). Phase I trial of bortezomib in combination with rituximab‐HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma. British Journal of Haematology. 151(1). 47–53. 36 indexed citations

7.

Thomas, David M., Robert M. Henshaw, Keith M. Skubitz, et al.. (2010). Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. The Lancet Oncology. 11(3). 275–280. 516 indexed citations breakdown →

8.

Vij, Ravi, Noemi Horvath, Andrew Spencer, et al.. (2009). An open‐label, phase 2 trial of denosumab in the treatment of relapsed or plateau‐phase multiple myeloma. American Journal of Hematology. 84(10). 650–656. 72 indexed citations

9.

Ellis, Georgiana K., Henry G. Bone, Rowan T. Chlebowski, et al.. (2008). Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer. Journal of Clinical Oncology. 26(30). 4875–4882. 342 indexed citations

10.

Romaguera, Jorge, Luis Fayad, Peter McLaughlin, et al.. (2008). Phase I Trial of Bortezomib in Combination with Rituximab-HyperCVAD/Methotrexate and Cytarabine for Untreated Mantle Cell Lymphoma. Blood. 112(11). 3051–3051. 6 indexed citations

11.

Smith, J. W. G., et al.. (2004). Planning a developmentally appropriate neonatal intensive care unit. Clinics in Perinatology. 31(2). 313–322. 6 indexed citations

12.

Kipling, M. D., et al.. (1998). Anaesthetic management of a woman who became paraplegic at 22 weeks' gestation after a spontaneous spinal cord haemorrhage secondary to a presumed arteriovenous malformation. British Journal of Anaesthesia. 81(6). 976–978. 11 indexed citations

13.

Gaynes, Robert P., Robert A. Weinstein, J. W. G. Smith, Margaret Carman, & S. A. Kabins. (1983). Control of Aminoglycoside Resistance by Barrier Precautions. Infection Control. 4(4). 221–225. 16 indexed citations

14.

Smith, J. W. G., et al.. (1976). The response to oral poliovaccine in persons aged 16–18 years. Journal of Hygiene. 76(2). 235–247. 17 indexed citations

15.

Smith, J. W. G., Laurence Després, & D. Gareth Evans. (1975). Prevention of tetanus in the wounded.. BMJ. 3(5981). 453–455. 15 indexed citations

16.

Smith, J. W. G., et al.. (1975). Reactions to injected influenza vaccine.. PubMed. 28. 377–88. 9 indexed citations

17.

Gall, D., et al.. (1969). DURATION OF IMMUNITY AFTER ACTIVE IMMUNISATION AGAINST TETANUS. The Lancet. 294(7611). 95–96. 19 indexed citations

18.

Smith, J. W. G.. (1964). Penicillin in Prevention of Tetanus. BMJ. 2(5420). 1293–1296. 16 indexed citations

19.

Evans, D. Gareth & J. W. G. Smith. (1963). RESPONSE OF THE YOUNG INFANT TO ACTIVE IMMUNIZATION. British Medical Bulletin. 19(3). 225–229. 12 indexed citations

20.

Smith, J. W. G.. (1963). Immunization against Diphtheria and Tetanus. International Journal of Clinical Practice. 17(11). 683–687. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact